Biodegradable controlled drug delivery systems for the treatment of brain diseases

Project Information

BCDDS

Grant agreement ID: QLK3-CT-2001-02226

Project closed

Start date 1 January 2002

End date 31 December 2004

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 2 226 543,00

EU contribution € 2 097 246,00

Coordinated by

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

Objective

The major objective of the present proposal is to develop new therapeutic strategies for the treatment of brain diseases. The aim is to restore, maintain and improve cell, tissue and organ functions within the Central Nervous System (CNS). Emphasis is on two kinds of diseases: brain cancer and neurodegenerative disorders, namely Parkinson ' s and Huntington ' s Disease. The treatment of CNS diseases is very difficult due to the Blood Brain Barrier, hindering most drugs to reach the brain tissue. Thus, target-specific delivery systems are required. Using a multi-disciplinary approach we will develop new pharmaceutical devices releasing highly potent drugs in a controlled manner into the CNS. The whole range of innovation, from advanced research, through technological development up to in vivo evaluation will be covered. With an industrial company in the consortium, also the economic exploitation of the outcoming scientific results is foreseen.

Fields of science

• natural sciences › biological sciences › neurobiology
• medical and health sciences › clinical medicine › oncology
• medical and health sciences › basic medicine › neurology › parkinson

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-3. - Key action The "Cell factory"

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

• EU contribution: No data
• Address: Rue AndrT Boquel 10 ; 49100 ANGERS ; France
• Total cost: No data

Participants (5)

FREIE UNIVERSITAET BERLIN

Germany

• EU contribution: No data
• Address: Kelchstrasse 31 ; 12169 BERLIN
• Total cost: No data

UNIVERSITAET REGENSBURG

Germany

• EU contribution: No data
• Address: Universitaetsstrasse 31 ; 93040 REGENSBURG
• Total cost: No data

UNIVERSITE D'ANGERS

France

• EU contribution: No data
• Address: Rue Larrey ; 49033 ANGERS
• Total cost: No data

UNIVERSITE D'ANGERS

France

• EU contribution: No data
• Address: Rue AndrT Boquel 10, BFtiment IBT ; 49100 ANGERS
• Total cost: No data

UNIVERSITY OF LONDON

United Kingdom

• EU contribution: No data
• Address: MALET STREET, SENATE HOUSE ; WC1E7HU LONDON
• Total cost: No data